Interestingly, these two “writer” genes, METTL3 and METTL14, showed an opposite effect on survival of ccRCC patients, which hinted that the “writers” exerted as a complicated regulators in ccRCC. Here, METTL14 is linked to nonpapillary renal cell carcinoma.